Mantle Cell Lymphoma - 25 Studies Found Completed : Study of Mantle Cell Lymphoma Treatment by RiBVD : Mantle Cell Lymphoma : 2011-10-20 : Drug: RiBVD Every cycle: Completed : Intensive Induction Therapy Followed by High Dose Chemo and BM Transplant for Mantle Cell Lymphoma : Mantle Cell Lymphoma : 2007-12-21 : Procedure: Intensive Induction-BMT Patients will undergo an induction regimen consisting of 1 cycle of c Not yet recruiting : The Efficacy and Safety of Bortezomib Combined With Fludarabine and Cytarabine Treatment for Mantle Cell Lymphoma : Mantle Cell Lymphoma : 2016-10-11 : Drug: Bortezomib Bortezomib(V) Completed : Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma : Mantle-Cell Lymphoma : 2009-04-07 : Biological: G-CSF Granulocyte- Completed : Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma : Mantle Cell Lymphoma : 2005-07-07 : Drug: Fludarabine Given on day Completed : Rituximab, Lenalidomide, and Bortezomib in Mantle Cell Lymphoma : Mantle Cell Lymphoma : 2008-03-04 : Drug: Rituximab Completed : Safety Study to Evaluate Induction and Consolidation Treatment in Patients With Mantle Cell Lymphoma (LCM-04-02) : Mantle Cell Lymphoma : 2007-07-20 : Drug: Y-90 Ibritumomab tiuxetan Study Design Completed : A Study to Evaluate the Efficacy and Safety of Ibrutinib, in Patients With Mantle Cell Lymphoma Who Progress After Bortezomib Therapy : Mantle Cell Lymphoma : 2012-05-14 : Drug: Ibrutinib Type=exact number, unit=mg, number=560, form=capsule, route=oral use. 560 mg oral ibruti Active, not recruiting : Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma. : Mantle Cell Lymphoma : 2009-08-20 : Drug: lenalidomide, bendamustine, rituximab Completed : Study of Ibrutinib (a Bruton's Tyrosine Kinase Inhibitor), Versus Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy : Mantle Cell Lymphoma : 2012-07-18 : Drug: Ibrutinib 560 mg once da Next >>>
